PARANEOPLASTIC ENCEPHALOMYELITIS

PARANEOPLASTIC ENCEPHALOMYELITIS was reported 46 times

PARANEOPLASTIC ENCEPHALOMYELITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
1 Osmotic Diuretic [EPC] 1 0.0002
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 17 0.0002
3 Programmed Death Ligand-1 Blocker [EPC] 3 0.0001
4 Topoisomerase Inhibitor [EPC] 7 0.0001
5 Human Immunoglobulin G [EPC] 1 0.0000
6 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 4 0.0000
7 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
8 Platinum-based Drug [EPC] 9 0.0000
9 Vitamin B12 [EPC] 9 0.0000
10 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
11 Vitamin D [EPC] 8 0.0000
12 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
13 Vitamin C [EPC] 8 0.0000
14 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
15 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
16 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
17 Prostaglandin Analog [EPC] 1 0.0000
18 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 Corticosteroid [EPC] 11 0.0000
20 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
21 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
22 Benzodiazepine [EPC] 5 0.0000
23 Azole Antifungal [EPC] 1 0.0000
24 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
25 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
26 Anti-epileptic Agent [EPC] 1 0.0000
27 Insulin Analog [EPC] 2 0.0000
28 Opioid Agonist [EPC] 1 0.0000
29 beta-Adrenergic Blocker [EPC] 1 0.0000
30 Tumor Necrosis Factor Blocker [EPC] 1 0.0000